154 related articles for article (PubMed ID: 10807898)
1. Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis.
Scarpa A; Di Pace C; Talamini G; Falconi M; Lemoine NR; Iacono C; Achille A; Baron A; Zamboni G
Gut; 2000 Jun; 46(6):842-8. PubMed ID: 10807898
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.
Iacono C; Verlato G; Zamboni G; Scarpa A; Montresor E; Capelli P; Bortolasi L; Serio G
J Gastrointest Surg; 2007 May; 11(5):578-88. PubMed ID: 17468917
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of mutator phenotype and chromosome 17p and 18q allelic loss in gastric cancer.
de Manzoni G; Tomezzoli A; Di Leo A; Moore PS; Talamini G; Scarpa A
Br J Surg; 2001 Mar; 88(3):419-25. PubMed ID: 11260110
[TBL] [Abstract][Full Text] [Related]
4. Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients.
Wang W; Li YF; Sun XW; Chen G; Zhan YQ; Huang CY; Wan DS; Pan ZZ; Zhou ZW
Chin J Cancer; 2010 Aug; 29(8):761-7. PubMed ID: 20663324
[TBL] [Abstract][Full Text] [Related]
5. Allelotype of ampulla of Vater cancer: highly frequent involvement of chromosome 11.
Moore PS; Missiaglia E; Beghelli S; Bragantini E; Mina MM; Zamboni G; Falconi M; Scarpa A
J Cancer Res Clin Oncol; 2004 Jun; 130(6):339-45. PubMed ID: 15024645
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity in ampulla of Vater neoplasms during adenoma-carcinoma sequence.
Park S; Kim SW; Kim SH; Lee BL; Kim WH
Anticancer Res; 2003; 23(3C):2955-9. PubMed ID: 12926143
[TBL] [Abstract][Full Text] [Related]
7. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma.
Lindforss U; Fredholm H; Papadogiannakis N; Gad A; Zetterquist H; Olivecrona H
Cancer; 2000 Jun; 88(12):2661-7. PubMed ID: 10870047
[TBL] [Abstract][Full Text] [Related]
8. Cancers of the papilla of vater: mutator phenotype is associated with good prognosis.
Achille A; Biasi MO; Zamboni G; Bogina G; Iacono C; Talamini G; Capella G; Scarpa A
Clin Cancer Res; 1997 Oct; 3(10):1841-7. PubMed ID: 9815572
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma.
Franko J; Krasinskas AM; Nikiforova MN; Zarnescu NO; Lee KK; Hughes SJ; Bartlett DL; Zeh HJ; Moser AJ
J Gastrointest Surg; 2008 Oct; 12(10):1664-72; discussion 1672-3. PubMed ID: 18677542
[TBL] [Abstract][Full Text] [Related]
10. Involvement of 1p36 region in two cases of adenocarcinoma of the ampulla of Vater.
Bernasconi B; Dossena B; Billo PR; Tibiletti MG; Sessa F
Cancer Genet Cytogenet; 2002 Oct; 138(2):133-8. PubMed ID: 12505258
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 18q allelic loss and prognosis in stage II and III colon cancer.
Lanza G; Matteuzzi M; Gafá R; Orvieto E; Maestri I; Santini A; del Senno L
Int J Cancer; 1998 Aug; 79(4):390-5. PubMed ID: 9699532
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
[TBL] [Abstract][Full Text] [Related]
13. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma.
Yatsuoka T; Sunamura M; Furukawa T; Fukushige S; Yokoyama T; Inoue H; Shibuya K; Takeda K; Matsuno S; Horii A
Am J Gastroenterol; 2000 Aug; 95(8):2080-5. PubMed ID: 10950061
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancer.
Kambara T; Sharp GB; Nagasaka T; Takeda M; Sasamoto H; Nakagawa H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
Clin Cancer Res; 2004 Mar; 10(5):1758-63. PubMed ID: 15014029
[TBL] [Abstract][Full Text] [Related]
15. Allelic status of chromosomes 17p, 18q, 22q [corrected] 3p and their clinical usefulness in colorectal cancer.
Fujita S; Baba H; Yamamoto S; Akasu T; Moriya Y; Sugano K
Anticancer Res; 2006; 26(4B):2833-40. PubMed ID: 16886602
[TBL] [Abstract][Full Text] [Related]
16. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.
Martínez-López E; Abad A; Font A; Monzó M; Ojanguren I; Pifarré A; Sánchez JJ; Martín C; Rosell R
Gastroenterology; 1998 Jun; 114(6):1180-7. PubMed ID: 9609754
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of heterozygosity at the DCC locus in gastric cancer.
Uchino S; Tsuda H; Noguchi M; Yokota J; Terada M; Saito T; Kobayashi M; Sugimura T; Hirohashi S
Cancer Res; 1992 Jun; 52(11):3099-102. PubMed ID: 1591722
[TBL] [Abstract][Full Text] [Related]
18. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
Ogunbiyi OA; Goodfellow PJ; Herfarth K; Gagliardi G; Swanson PE; Birnbaum EH; Read TE; Fleshman JW; Kodner IJ; Moley JF
J Clin Oncol; 1998 Feb; 16(2):427-33. PubMed ID: 9469325
[TBL] [Abstract][Full Text] [Related]
19. Allelic loss of chromosome 18q and prognosis in colorectal cancer.
Jen J; Kim H; Piantadosi S; Liu ZF; Levitt RC; Sistonen P; Kinzler KW; Vogelstein B; Hamilton SR
N Engl J Med; 1994 Jul; 331(4):213-21. PubMed ID: 8015568
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy as a major prognostic factor in resectable ampulla of Vater cancers.
Shyr YM; Su CH; Wu LH; Li AF; Chiu JH; Lui WY
J Surg Oncol; 1993 Aug; 53(4):220-5. PubMed ID: 8101889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
